Physician profile
Bassel Ramadan
NPI 1487603361
$1,704.40
in general payments reported to CMS, 2019-2025
18 companies · $1,316 in 2025
The $1,316 reported for 2025 was more than what 81% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.97 · 2020: $42.87 · 2021: $50.00 · 2022: $18.44 · 2023: $24.96 · 2024: $177 · 2025: $1,316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,498 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,498.12 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $455.62 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $286.23 | 2025 | Fasenra, Tezspire, Breztri |
| Inspire Medical Systems, INC. | $215.69 | 2025 | Inspire |
| Verona Pharma, INC. | $131.72 | 2025 | Ohtuvayre |
| Genzyme Corporation | $126.46 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $125.46 | 2024-2025 | Dupixent |
| Insmed, INC. | $58.36 | 2025 | Arikayce, Brinsupri |
| Ceribell, INC. | $42.36 | 2024 | Pocket Eeg Device |
| Inogen, INC. | $38.64 | 2025 | |
| Acera Surgical, INC. | $37.95 | 2025 | Restrata Wound Matrix |
| Pulmonx Corporation | $36.94 | 2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Ets Wound Care LLC | $29.93 | 2025 | Mirragen Advanced Wound Matrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.69 | 2025 | Jascayd |
| Philips North America LLC | $20.84 | 2019 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $18.44 | 2022 | |
| Genentech USA, INC. | $18.31 | 2019 | |
| Lilly USA, LLC | $16.76 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bassel Ramadan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.